Low-grade myxofibrosarcoma following a metal implantation in femur: a case report

Diagnostic Pathology

Qingchun Yang⁴  Chunlei He¹  Shaohui Lu²  Xiansen Zhu⁴  Dan Li³  Weisong Li⁵ 

[1] Department of Orthopedics, the First Affiliated Hospital, Gannan Medical University, No. 23, Qingnian Road, Ganzhou, Jiangxi 341000, China;Department of Radiology, the First Affiliated Hospital, Gannan Medical University, No. 23, Qingnian Road, Ganzhou, Jiangxi 341000, China;Translational Medicine Research and Development Center, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, No. 1068 Xueyuan Avenue, Shenzhen, Guangdong 518055, China;Department of Pathology, Gannan Medical University, No. 1, Yixueyuan Road, Ganzhou, Jiangxi 341000, China;Department of Pathology, the First Affiliated Hospital, Sun Yat-Sen University, No. 58, Zhongshan Road II, Guangzhou, Guangdong 510080, China

关键词: Metal implantation;    Titanium alloy;    Fracture;    Femur;    Myxofibrosarcoma;   

Others  :  803553
DOI  :  10.1186/1746-1596-9-6

 received in 2013-11-20, accepted in 2013-12-27,  发布年份 2014

【 摘 要 】

Myxofibrosarcoma is a myxoid variant of malignant fibrous histiocytoma that most commonly involves the extremities of elderly people. However, a primary myxofibrosarcoma with bone invasion in young adults is extremely rare. Herein, we report the case of a 31-year-old male with a gradually enlarging left thigh mass, who had a history of left femur fracture and received an open reduction and internal fixation with titanium alloy plates and screws 33 months previously. Imaging investigations revealed an irregularly shaped soft tissue mass around the left femur shaft and a partial bone defect in the middle one-third of the left femur. Pathological examination of the resected specimen showed a multi-nodular appearance, abundant myxoid matrix and elongated curvilinear capillaries. Immunohistochemical studies revealed that the tumor cells was positive for VIM and MDM2, and was negative for CK, MSA, SMA, DES, S-100 and CD34. Labeling index of Ki-67 was 25%. Based on the morphological finding and immunostaining, it was diagnosed as a low-grade myxofibrosarcoma. The clinical and imaging examinations did not reveal the evidence of a primary cancer elsewhere, and the patient had no personal or family history of malignancy. To our knowledge, this is the first case of a primary myxofibrosarcoma developed following a fracture and metal implantation in young adults.

Virtual slides

The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/vs/1745984882113605 webcite

【 授权许可】

   
2014 Li et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Angervall L, Kindblom LG, Merck C: Myxofibrosarcoma. A study of 30 cases. Acta Pathol Microbiol Scand A 1977, 85A(2):127-140.
• [2]Weiss SW, Enzinger FM: Myxoid variant of malignant fibrous histiocytoma. Cancer 1977, 39(4):1672-1685.
• [3]Mentzel T, Calonje E, Wadden C, Camplejohn RS, Beham A, Smith MA, Fletcher CD: Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant. Am J Surg Pathol 1996, 20(4):391-405.
• [4]Wang JG, Li YJ, Liu H, Zhao P: Primary cardiac myxofibrosarcoma: a case report and review of the literature. Tumori 2012, 98(6):e165-e168.
• [5]Kapur P, Sarode V: Pathologic quiz case: myxoid tibial lesion in a 31-year-old man. Low-grade myxofibrosarcoma. Arch Pathol Lab Med 2004, 128(4):e65-e66.
• [6]Marotta D, Angeloni M, Salgarello M, Ricciardella ML, Chalidis B, Maccauro G: Surgical treatment of a giant tibial high-grade mixofibrosarcoma with preservation of limb function: a case report. Int Semin Surg Oncol 2009, 6:16. BioMed Central Full Text
• [7]Romeo S, Bovée JV, Kroon HM, Tirabosco R, Natali C, Zanatta L, Sciot R, Mertens F, Athanasou N, Alberghini M, Szuhai K, Hogendoorn PC, Dei Tos AP: Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches. Virchows Arch 2012, 461(5):561-570.
• [8]Murphey MD, Gross TM, Rosenthal HG: From the archives of the AFIP. Musculoskeletal malignant fibrous histiocytoma: radiologic-pathologic correlation. Radiographics 1994, 14(4):807-826.
• [9]Nakayama K, Nemoto Y, Inoue Y, Mochizuki T, Soares SB Jr, Ohata K, Katsuyama J, Onoyama Y, Wakasa K: Malignant fibrous histiocytoma of the temporal bone with endocranial extension. AJNR Am J Neuroradiol 1997, 18(2):331-334.
• [10]Woodhams R, Kan S, Iwabuchi K, Oka H, Sagiuchi T, Hayakawa K: A case of malignant fibrous histiocytoma (MFH) in the skull bone presenting extensive permeative osteolysis. Radiat Med 2002, 20(3):141-145.
• [11]Park SW, Kim HJ, Lee JH, Ko YH: Malignant fibrous histiocytoma of the head and neck: CT and MR imaging findings. AJNR Am J Neuroradiol 2009, 30(1):71-76.
• [12]Merck C, Angervall L, Kindblom LG, Odén A: Myxofibrosarcoma. A malignant soft tissue tumor of fibroblastic-histiocytic origin. A clinicopathologic and prognostic study of 110 cases using multivariate analysis. Acta Pathol Microbiol Immunol Scand Suppl 1983, 282:1-40.
• [13]Lin XY, Wang Y, Yu JH, Liu Y, Wang L, Li QC, Wang EH: Sclerosing rhabdomyosarcoma presenting in the masseter muscle: a case report. Diagn Pathol 2013, 8:18. BioMed Central Full Text
• [14]Peng L, Liu Y, Ai Y, Liu Z, He Y, Liu Q: Skull base metastases from a malignant solitary fibrous tumor of the liver. A case report and literature review. Diagn Pathol 2011, 6:127. BioMed Central Full Text
• [15]Binh MB, Sastre-Garau X, Guillou L, de Pinieux G, Terrier P, Lagacé R, Aurias A, Hostein I, Coindre JM: MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 2005, 29(10):1340-1347.
• [16]Oda Y, Takahira T, Kawaguchi K, Yamamoto H, Tamiya S, Matsuda S, Tanaka K, Kinukawa N, Iwamoto Y, Tsuneyoshi M: Altered expression of cell cycle regulators in myxofibrosarcoma, with special emphasis on their prognostic implications. Hum Pathol 2003, 34(10):1035-1042.
• [17]Kimura H, Dobashi Y, Nojima T, Nakamura H, Yamamoto N, Tsuchiya H, Ikeda H, Sawada-Kitamura S, Oyama T, Ooi A: Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics. Int J Clin Exp Pathol 2013, 6(7):1306-1316.
• [18]Kuo JR, Chio CC, Wang CC, Chu YH, Lin KC, Chuang SS: Radiation-induced intra- and extra-cranial high-grade myxofibrosarcoma with tumor bleeding. J Clin Neurosci 2008, 15(10):1151-1154.
• [19]Tearada H, Nagata M, Mugiya S, Ozono S: High-grade myxofibrosarcoma presenting at the spermatic cord after radiotherapy for prostate cancer. BMJ Case Rep 2012,  . doi: 10.1136/bcr-03-2012-6082
• [20]Urist MR: Trauma and neoplasm; report of a case of desmoid tumor following simple fracture of the radius and ulna. Am J Surg 1957, 93(4):682-688.
• [21]Langer F, Pritzker KP, Gross AE, Shapiro II: Giant cell tumor associated with trauma. Clin Orthop Relat Res 1982, 164:245-248.
• [22]Oppenheimer BS, Oppenheimer ET, Danishefsky I, Stout AP: Carcinogenic effect of metals in rodents. Cancer Res 1956, 16(5):439-441.
• [23]McDougall A: Malignant tumour at site of bone plating. J Bone Joint Surg Br 1956, 38-B(3):709-713.
• [24]Delgado ER: Sarcoma following a surgically treated fractured tibla; a case report. Clin Orthop 1958, 12:315-318.
• [25]Dube VE, Fisher DE: Hemangioendothelioma of the leg following metallic fixation of the tibia. Cancer 1972, 30(5):1260-1266.
• [26]Tayton KJ: Ewing's sarcoma at the site of a metal plate. Cancer 1980, 45(2):413-415.
• [27]McDonald I: Malignant lymphoma associated with internal fixation of a fractured tibia. Cancer 1981, 48(4):1009-1011.
• [28]Penman HG, Ring PA: Osteosarcoma in association with total hip replacement. J Bone Joint Surg Br 1984, 66(5):632-634.
• [29]Bagó-Granell J, Aguirre-Canyadell M, Nardi J, Tallada N: Malignant fibrous histiocytoma of bone at the site of a total hip arthroplasty. A case report. J Bone Joint Surg Br 1984, 66(1):38-40.
• [30]Swann M: Malignant soft-tissue tumor at the site of a total hip replacement. J Bone Joint Surg Br 1984, 66(5):629-631.
• [31]Weber PC: Epithelioid sarcoma in association with total knee replacement. A case report. J Bone Joint Surg Br 1986, 68(5):824-826.
• [32]Hughes AW, Sherlock DA, Hamblen DL, Reid R: Sarcoma at the site of a single hip screw. A case report. J Bone Joint Surg Br 1987, 69(3):470-472.
• [33]Haag M, Adler CP: Malignant fibrous histiocytoma in association with hip replacement. J Bone Joint Surg Br 1989, 71(4):701.
• [34]Sunderman FW Jr: Carcinogenicity of metal alloys in orthopedic prostheses: clinical and experimental studies. Fundam Appl Toxicol 1989, 13(2):205-216.
• [35]Ward JJ, Thornbury DD, Lemons JE, Dunham WK: Metal-induced sarcoma. A case report and literature review. Clin Orthop Relat Res 1990, 252:299-306.
• [36]Khurana JS, Rosenberg AE, Kattapuram SV, Fernandez OS, Ehara S: Malignancy supervening on an intramedullary nail. Clin Orthop Relat Res 1991, 267:251-254.
• [37]Gatti GM, Ivaldi GB, Lartigau E, Marsiglia H, Orecchia R: A Case of RhabdomyoSarcoma Following a Metal Surgical Implant. Sarcoma 1999, 3(2):145-147.
• [38]Hinarejos P, Escuder MC, Monllau JC, Alvarez P, Lloreta J, Ballester J: Fibrosarcoma at the site of a metallic fixation of the tibia–a case report and literature review. Acta Orthop Scand 2000, 71(3):329-332.
• [39]Adams JE, Jaffe KA, Lemons JE, Siegal GP: Prosthetic implant associated sarcomas: a case report emphasizing surface evaluation and spectroscopic trace metal analysis. Ann Diagn Pathol 2003, 7(1):35-46.
• [40]Albert A, Lootvoet L, Lejeune E, Beugnies A, Himmer O: Angiosarcoma around a knee arthroplasty. Report of a case and literature review. Acta Orthop Belg 2009, 75(4):549-553.
• [41]Palraj B, Paturi A, Stone RG, Alvarez H, Sebenik M, Perez MT, Bush LM: Soft tissue anaplastic large T-cell lymphoma associated with a metallic orthopedic implant: case report and review of the current literature. J Foot Ankle Surg 2010, 49(6):561-564.
• [42]Dorrestijn O, Jutte PC: Osteosarcoma in the distal femur two years after an ipsilateral femoral shaft fracture: a case report. J Med Case Rep 2011, 5:198. BioMed Central Full Text
• [43]Nuevo-Ordóñez Y, Montes-Bayón M, Blanco-González E, Paz-Aparicio J, Raimundez JD, Tejerina JM, Peña MA, Sanz-Medel A: Titanium release in serum of patients with different bone fixation implants and its interaction with serum biomolecules at physiological levels. Anal Bioanal Chem 2011, 401(9):2747-2754.
• [44]Coen N, Kadhim MA, Wright EG, Case CP, Mothersill CE: Particulate debris from a titanium metal prosthesis induces genomic instability in primary human fibroblast cells. Br J Cancer 2003, 88(4):548-552.